Longitude Capital Partners II, LLC

CIK 1647491 · last filed 2026-02-06

Longitude Capital Partners II, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider sold $1.1M of RPID on Feb 6, 2026. Across all open-market trades the lifetime net is +$16.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.09M

Companies

2

Total Filings

3

Lifetime Open-Market Net

$16.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPID 10%+ Owner 4,029,245 $1.76 $7.09M -$3.51M 2 2026-02-06
Aimmune Therapeutics, Inc. (AIMT) Delisted 10%+ Owner 7,122,130 $20.00M 1 2015-08-11

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-06 RPID Sell (S) −294,000 -$1.14M EDGAR
2026-02-03 RPID Mixed +2,601,465 -$2.21M EDGAR
2015-08-11 Aimmune Therapeutics, Inc. (AIMT) Delisted Mixed +29,738,520 $20.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.